Federal Food and Nutrition Grants

This funding opportunity supports researchers in planning high-risk, multi-center clinical studies focused on kidney, digestive, diabetes, and metabolic disorders, helping them develop essential protocols and administrative frameworks before conducting the actual trials.

This funding opportunity provides financial support for researchers developing innovative, non-opioid treatments for various types of pain, with a focus on early-stage studies and collaboration with underrepresented populations.

The purpose of this research is to systematically evaluate the diastereomeric composition of LEQVIO (Inclisiran), an FDA-approved, N-acetyl galactosamine (GalNAc)-conjugated siRNA drug, and to understand the biological/pharmacological activity of each diastereomer in LEQVIO through stereo chemically controlled synthesis and biological activity assessment using in vitro and animal models. The proposed studies will focus on 1) synthesis of each diastereomer of LEQVIO (Inclisiran) in stereo chemically pure form; 2) assessment of the biological activity of each stereo chemically pure diastereomer in inhibiting PCSK9 activity using in vitro assays and in a transgenic mouse model; 3) development of analytical methods to identify and characterize the stereochemical structure of each diastereomer in LEQVIO; and 4) assessment of the individual contribution of each diastereomer to the overall pharmacological activity of LEQVIO. Tools developed in this research can also be applied to other similar GalNAc-conjugated siRNAs specifically, and other siRNAs in general. Knowledge gained from this research will also contribute to the sameness evaluation of generic siRNAs, and to the quality control of oligonucleotide drugs.

This grant provides funding to nonprofit organizations, academic institutions, and government entities to develop innovative solutions that improve access to legal resources and services for underserved rural communities across the United States.

ICN GE

This funding opportunity provides financial support for organizations to host conferences and scientific meetings that address important public health issues relevant to the FDA's mission.

This funding opportunity supports predoctoral students in dual-degree programs at institutions without NIH-funded training programs, helping them pursue research and clinical training to become future physician-scientists.

This grant invites private sector companies and organizations to collaborate with USAID on projects that address economic growth, financial inclusion, and environmental sustainability, leveraging their resources and expertise to achieve shared development goals.

This funding opportunity supports the development of innovative tools and technologies aimed at advancing research and treatment in kidney, urologic, and hematologic diseases, encouraging projects that push scientific boundaries and have broad applications beyond individual research interests.

This funding opportunity provides $250,000 to a non-profit organization focused on breastfeeding education to develop training materials and enhance the skills of WIC staff nationwide.

The Food and Drug Administration's (FDA), Center for Drug Evaluation and Research (CDER), Office of New Drugs (OND), is announcing this Funding Opportunity Announcement (FOA) for a Cooperative Agreement. The proposed work directly supports the U.S. FDAs stated goal of protecting public health from unacceptable risks from nitrosamine impurities in human drugs. Although significant experimental and policy/regulatory initiatives have been undertaken in this area, there remains a need for further research into and development and refinement of translational and implementable practices that will protect the public against nitrosamine risks while ensuring continued safe access to critical therapeutic drugs. The aim is to improve the safety of human drugs with potential nitrosamine impurity liabilities. In addition to the work outlined above, the award recipient will assess how best to ensure that this research and practices development continues among industry members, non-profits, and/or academic institutions once the FDA funding for this cooperative agreement ends.

The purpose of this Funding Opportunity Announcement (FOA) is to support innovative multidisciplinary and multi-level research designed to develop and/or test interventions to optimize care of persons with Type 2 diabetes from populations with health/health care disparities concordant with evidence-based guidelines. NIH-designated health disparity populations include racial and ethnic minorities (Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asians, Native Hawaiians and other Pacific Islanders), sexual and gender minorities, socioeconomically disadvantaged populations, and underserved rural populations. Proposed projects would be expected to develop and/or test patient-centered strategies, which in addition to optimal glycemic control, would aim at completing other recommended guidelines (e.g., annual eye/foot and urine albumin exam, optimal blood pressure control, intake of ACEIs or ARBs/statin/aspirin and influenza/pneumonia vaccines).

The FY 2024 Team Nutrition Training Grants for Meal Pattern Modernization and Retention and Mentorship Opportunities will help State agencies build capacity for future implementation of the Final Rule, Child Nutrition Programs: Meal Patterns Consistent with the 2020-2025 Dietary Guidelines for Americans and address residual COVID-19 effects on staff retention in school meal programs. During school years (SY) 2020-2021, 2021-2022, and 2022-2023, the COVID-19 pandemic significantly exacerbated food insecurity, diet-related diseases, and health disparities. It also affected school meal service across the country. Schools experienced school foodservice labor shortages and staff turnover as well as supply chain disruptions. The COVID-19 public health emergency underscored the need to safeguard and continue to support healthy school environments; provide technical assistance, coaching, and mentoring to School Nutrition Professionals; and to capture and share the institutional knowledge of School Nutrition Professionals. The FY 2024 Team Nutrition Training Grant activities will allow State agencies to provide technical assistance to School Nutrition Professionals and help ensure they have the skills and knowledge to prepare and serve nutritious meals. The grant will also help School Nutrition Professionals pilot and implement coaching and mentoring programs and resources, and implement ways to capture and share the institutional, job specific knowledge of school nutrition directors, managers, and front-line staff. Ultimately, this will assist SFAs to: identify and apply ways to further improve the nutritional quality of school meals; meet meal pattern requirements and weekly dietary specifications for school meals; implement scratch cooking techniques; improve forecasting, procurement, and menu planning for school meals, and; build a knowledgeable and skilled labor force. Please review the full Request for Applications under the "Related Documents" tab of this announcement for a full description and requirements for application and award.

This program provides funding to local organizations in Arkansas to help reduce poverty and support low-income individuals through services like employment, education, housing, nutrition, and health.

The United States Department of Agriculture (USDA) Food and Nutrition Service (FNS) administers all USDA domestic nutrition assistance programs, including the Supplemental Nutrition Assistance Program (SNAP). SNAP is the cornerstone of USDAs nutrition assistance programs and is the largest program in the domestic hunger safety net. SNAP provides nutrition assistance benefits via an Electronic Benefit Transfer (EBT) card to millions of low-income people. These benefits help supplement household food budgets so recipients can purchase more healthy food. FNS is directly responsible for the authorization and oversight of retailers who accept Supplemental Nutrition Assistance Program (SNAP) benefits. This is accomplished jointly by the Retailer Policy Division (RPD) within SNAP, and the Office of Retailer Operations and Compliance. Currently, approximately 260,000 retailers are authorized to accept SNAP. Thousands of direct marketing farmers and farmers markets (DMFs and FMs) apply for SNAP authorization each year. Since 2012, FNS has supported the participation of DMFs and FMs in their efforts to attract more SNAP customers. FNS has supported individual DMFs (and FMs on behalf of DMFs), which meet specific requirements, in procuring low- or no-cost wireless Electronic Benefit Transfer (EBT) point-of-sale (POS) devices through the SNAP EBT Equipment Program. FNS has also awarded grants to provide: a) an e-commerce platform that enables DMFs to accept SNAP benefits online (SNAP/Federal Nutrition Programs Participation Assistance for Farmers and Farmers Markets), and b) a SNAP Mobile Transaction Processing Application and card reader that enable a DMF to accept SNAP by using their own smartphone as a POS device (Mobile Application Cooperative Agreement, SNAP Farmers and Markets).

This Notice of Funding Opportunity (NOFO) invites applications from institutions/organizations that propose to establish a Research Resource Center (RRC) for the NIDDK Nutrition Obesity Research Centers (NORC) Program. The NORC Program consists of eleven Centers across the nation that support and enhance the national research effort in nutrition and obesity through cutting-edge basic, clinical, translational, and health disparities research in nutrition science and obesity. In collaboration with the existing NORC program, the RRC will (1) provide administrative support for the entire NORC Program, (2) establish and curate a NORC Program website and centralized repository of research resources , (3) implement a multipronged approach to support and grow the early-to-midcareer research workforce, including individuals from diverse backgrounds, with a goal of maximizing national outreach and impact, (4) administer and manage a NORC Opportunity Program to address gaps and promote collaboration, and (5) manage a Pilot and Feasibility Program.This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn.

This Funding Opportunity Announcement (FOA) invites applications to develop and implement Phase Ib to III clinical trials of promising pharmacological and non-pharmacological interventions that may prevent, delay, or treat the symptoms of Alzheimer's disease (AD) and other age-related dementias using the Alzheimer's disease Clinical Trials Consortium (ACTC) trial coordination and management infrastructure.Research Objectives Utilizing the ACTC, the goal of this FOA is to invite research grant applications that provide clinical testing (Phases Ib-III) of promising pharmacological and/or non-pharmacological interventions for cognitive and neuropsychiatric symptoms in individuals with AD or other aging-related dementias across the spectrum from pre-symptomatic to more severe stages of disease. Working with the ACTC is a cooperative venture between the applicant, the NIA, and the ACTC network. NIA and the ACTC leadership will provide guidance to potential applicants. Potential applicants are strongly encouraged to contact NIA Scientific/Research Contacts (see Agency Contacts, Section VII) and the ACTC study team in order to discuss the feasibility of conducting the proposed trial through the ACTC infrastructure before considering an application. The ACTC infrastructure is welcoming of the following: Academic and industry applicants Pharmacological and non-pharmacological interventions Applications are encouraged that propose the following: Testing candidate therapeutic compounds against novel therapeutic targets Testing repurposed drugs derived from data-driven approaches, including candidates coming from NIA's translational bioinformatics FOA (PAR-17-032) Logistical guidance: Potential applicants undergo initial vetting of proposed study by the ACTC protocol evaluation committee and final review by the steering committee. Applicants should contact the ACTC study team at least 5 months prior to their desired NIA submission cycle. Contact details and more information may be found at actcinfo.org. Applications should anticipate using a centralized IRB. Applicants should be aware of the data and resource sharing requirements. The use of common contract language is strongly encouraged. Note, the ACTC infrastructure is not appropriate for: Single site clinical trials Routine Phase Ia first-in-human Clinical trials funded from this FOA will be implemented through the ACTC. The clinical trials approved for funding will develop their final protocols in conjunction with the ACTC. All ACTC sites will have the option to request participation and will be selected based on their capabilities specific to the individual protocols. Investigators are strongly encouraged to collect blood and other biosamples for future genomic and other 'omic' analyses aimed at interrogating treatment responsiveness and examining predictors of decline and progression. See Section VIII. Other Information for award authorities and regulations.

This funding opportunity provides financial support to early-career faculty at institutions with limited NIH funding to help them establish independent biomedical research programs and enhance student research experiences.

This funding program provides financial support to local social service organizations across the U.S. to help individuals and families facing emergency food and shelter needs.

This funding opportunity provides significant financial support to U.S. higher education institutions and research organizations with established HIV/AIDS research programs, enabling them to enhance their research infrastructure and foster interdisciplinary collaboration in the fight against HIV/AIDS.